MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circulationaha.121.055610

Медицинская библиотека · Circulation · 2022

Circulating c-Met-Expressing Memory T Cells Define Cardiac Autoimmunity.

Fanti Silvia, Stephenson Edward, Rocha-Vieira Etel, Protonotarios Alexandros, Kanoni Stavroula, Shahaj Eriomina, Longhi M Paula, Vyas Vishal S, Dyer Carlene, Pontarini Elena, Asimaki Angeliki, Bueno-Beti Carlos, De Gaspari Monica, Rizzo Stefania, Basso Cristina, Bombardieri Michele, Coe David, Wang Guosu, Harding Daniel, Gallagher Iain, Solito Egle, Elliott Perry, Heymans Stephane, Sikking Maurits, Savvatis Konstantinos, Mohiddin Saidi A, Marelli-Berg Federica M

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Autoimmunity is increasingly recognized as a key contributing factor in heart muscle diseases. The functional features of cardiac autoimmunity in humans remain undefined because of the challenge of studying immune responses in situ. We previously described a subset of c-mesenchymal epithelial transition factor (c-Met)-expressing (c-Met+) memory T lymphocytes that preferentially migrate to cardiac tissue in mice and humans.

METHODS

In-depth phenotyping of peripheral blood T cells, including c-Met+ T cells, was undertaken in groups of patients with inflammatory and noninflammatory cardiomyopathies, patients with noncardiac autoimmunity, and healthy controls. Validation studies were carried out using human cardiac tissue and in an experimental model of cardiac inflammation.

RESULTS

We show that c-Met+ T cells are selectively increased in the circulation and in the myocardium of patients with inflammatory cardiomyopathies. The phenotype and function of c-Met+ T cells are distinct from those of c-Met-negative (c-Met-) T cells, including preferential proliferation to cardiac myosin and coproduction of multiple cytokines (interleukin-4, interleukin-17, and interleukin-22). Furthermore, circulating c-Met+ T cell subpopulations in different heart muscle diseases identify distinct and overlapping mechanisms of heart inflammation. In experimental autoimmune myocarditis, elevations in autoantigen-specific c-Met+ T cells in peripheral blood mark the loss of immune tolerance to the heart. Disease development can be halted by pharmacologic c-Met inhibition, indicating a causative role for c-Met+ T cells.

CONCLUSIONS

Our study demonstrates that the detection of circulating c-Met+ T cells may have use in the diagnosis and monitoring of adaptive cardiac inflammation and definition of new targets for therapeutic intervention when cardiac autoimmunity causes or contributes to progressive cardiac injury.

Для цитирования: Fanti Silvia, Stephenson Edward, Rocha-Vieira Etel, Protonotarios Alexandros, Kanoni Stavroula, Shahaj Eriomina, Longhi M Paula, Vyas Vishal S, Dyer Carlene, Pontarini Elena, Asimaki Angeliki, Bueno-Beti Carlos, De Gaspari Monica, Rizzo Stefania, Basso Cristina, Bombardieri Michele, Coe David, Wang Guosu, Harding Daniel, Gallagher Iain, Solito Egle, Elliott Perry, Heymans Stephane, Sikking Maurits, Savvatis Konstantinos, Mohiddin Saidi A, Marelli-Berg Federica M. Circulating c-Met-Expressing Memory T Cells Define Cardiac Autoimmunity.. Circulation. 2022. DOI: 10.1161/circulationaha.121.055610.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.